Dear Foregen Supporters,
Welcome back to our most recent newsletter. We have some important updates for you, and an overview of the best parts of December.
What’s Happened Since Last Time
- Within the past week the paper we published is now the #1 most read and downloaded article from SAGE Journal of Tissue Engineering, with 6,883 views and downloads at the time of this newsletter, and growing.
- On New Year’s Eve we received the largest single donation in Foregen’s history of $10,000, leading to the largest month on record so far for our organization. A special thanks to this generous donor for giving us a great start to 2019.
- Eric Cunningham is finishing up a breakdown of the scientific paper to explain some of the important aspects and results. We’ll publish this on our blog as well as across social media as soon as it’s available, so be on the lookout!
- Some updates should be made within the next several weeks explaining our next steps.
- For the month of December overall we reached a total of $21,251 in donations, which helps us move forward with the next parts of our mission! Be sure to inform other activists, friends and family about Foregen and the science we’re pursuing to one day help provide genital integrity to men around the world. Our overall total to date is $403,784 - Let’s keep it up.
Tell Me Something Interesting
- This article gives a good breakdown of 3D bioprinting and how it works along with its different applications in the field now and potential future uses.
- A new study from the NYU School of Medicine demonstrated that ‘the healing of wounded skin in diabetes can be sped up by more than 50 percent using injections of stem cells taken from bone marrow, a new study in mice shows.’
Volunteer for Foregen
If you are interested in any of the following positions, please click on them to read more and apply:
Thanks for reading, and stay tuned for our next newsletter. If you’d like more frequent updates, please head over to our blog, or visit one of our social media accounts – the links are at the bottom of this newsletter.
The Foregen Team